Trial Profile
A Phase II Study in Japan of the Safety and Antiviral Activity of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2010
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 18 Dec 2009 New trial record